Wells Fargo’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,406
| Closed | -$2.69M | – | 7324 |
|
|
2020
Q4 | $2.69M | Sell |
20,406
-3,306
| -14% | -$435K | ﹤0.01% | 3240 |
|
|
2020
Q3 | $1.2M | Buy |
23,712
+1,865
| +9% | +$94.3K | ﹤0.01% | 3637 |
|
|
2020
Q2 | $1.04M | Buy |
21,847
+4,091
| +23% | +$195K | ﹤0.01% | 3697 |
|
|
2020
Q1 | $871K | Buy |
17,756
+5,196
| +41% | +$255K | ﹤0.01% | 3536 |
|
|
2019
Q4 | $721K | Buy |
12,560
+6,178
| +97% | +$355K | ﹤0.01% | 4013 |
|
|
2019
Q3 | $230K | Buy |
6,382
+59
| +0.9% | +$2.13K | ﹤0.01% | 4704 |
|
|
2019
Q2 | $196K | Sell |
6,323
-3,300
| -34% | -$102K | ﹤0.01% | 4804 |
|
|
2019
Q1 | $225K | Buy |
9,623
+5,319
| +124% | +$124K | ﹤0.01% | 4693 |
|
|
2018
Q4 | $59K | Buy |
4,304
+3,278
| +319% | +$44.9K | ﹤0.01% | 5196 |
|
|
2018
Q3 | $10K | Buy |
+1,026
| New | +$10K | ﹤0.01% | 5608 |
|